Clinical Detection and Treatment of Adrenal Disease

  • Adrian M. Harvey
  • Allan A. Siperstein
  • Eren Berber
Chapter
Part of the Molecular Pathology Library book series (MPLB, volume 3)

Abstract

Diagnosis and treatment of patients with adrenal lesions is both challenging and fascinating owing to the wide range of biologically important compounds produced by these small glands. Tumors of the adrenal cortex may produce mineralocorticoids, glucocorticoids, sex steroids or in specific cases, combinations of these. Tumors of the adrenal medulla may produce catecholamines and other related compounds making them particularly challenging to diagnose and treat. Malignant disease of the adrenal glands may also be hormonally active.

Keywords

Osteoporosis Adenoma Cortisol Dexamethasone Glucocorticoid 

References

  1. 1.
    Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing’s syndrome. Lancet. 2006;367(9522):1605–1617.CrossRefPubMedGoogle Scholar
  2. 2.
    Charbonnel B, Chatal JF, Ozanne P. Does the corticoadrenal adenoma with “pre-Cushing’s syndrome” exist? J Nucl Med. 1981;22(12):1059–1061.PubMedGoogle Scholar
  3. 3.
    Barzon L, Fallo F, Sonino N, Boscaro M. Development of overt Cushing’s syndrome in patients with adrenal incidentaloma. Eur J Endocrinol. 2002;146(1):61–66.CrossRefPubMedGoogle Scholar
  4. 4.
    Ilias I, Torpy DJ, Pacak K, Mullen N, Wesley RA, Nieman LK. Cushing’s syndrome due to ectopic corticotropin secretion: twenty years’ experience at the National Institutes of Health. J Clin Endocrinol Metab. 2005;90(8):4955–4962.CrossRefPubMedGoogle Scholar
  5. 5.
    Lindholm J, Juul S, Jorgensen JO, et al. Incidence and late prognosis of Cushing’s syndrome: a population-based study. J Clin Endocrinol Metab. 2001;86(1):117–123.CrossRefPubMedGoogle Scholar
  6. 6.
    Arnaldi G, Angeli A, Atkinson AB, et al. Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab. 2003;88(12):5593–5602.CrossRefPubMedGoogle Scholar
  7. 7.
    Findling JW, Kehoe ME, Raff H. Identification of patients with Cushing’s disease with negative pituitary adrenocorticotropin gradients during inferior petrosal sinus sampling: prolactin as an index of pituitary venous effluent. J Clin Endocrinol Metab. 2004;89(12):6005–6009.CrossRefPubMedGoogle Scholar
  8. 8.
    Rockall AG, Babar SA, Sohaib SA, et al. CT and MR imaging of the adrenal glands in ACTH-independent Cushing syndrome. Radiographics. 2004;24(2):435–452.CrossRefPubMedGoogle Scholar
  9. 9.
    Invitti C, Pecori GF, de Martin M, Cavagnini F. Diagnosis and management of Cushing’s syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis. J Clin Endocrinol Metab. 1999;84(2):440–448.CrossRefPubMedGoogle Scholar
  10. 10.
    Lindsay JR, Nieman LK. Differential diagnosis and imaging in Cushing’s syndrome. Endocrinol Metab Clin North Am. 2005;34(2):403-421, x.CrossRefPubMedGoogle Scholar
  11. 11.
    Iacobone M, Mantero F, Basso SM, Lumachi F, Favia G. Results and long-term follow-up after unilateral adrenalectomy for ACTH-independent hypercortisolism in a series of fifty patients. J Endocrinol Invest. 2005;28(4):327–332.PubMedGoogle Scholar
  12. 12.
    Mishra AK, Agarwal A, Gupta S, Agarwal G, Verma AK, Mishra SK. Outcome of adrenalectomy for Cushing’s syndrome: experience from a tertiary care center. World J Surg. 2007;31(7):1425–1432.CrossRefPubMedGoogle Scholar
  13. 13.
    Gumbs AA, Gagner M. Laparoscopic adrenalectomy. Best Pract Res Clin Endocrinol Metab. 2006;20(3):483–499.CrossRefPubMedGoogle Scholar
  14. 14.
    Sonino N, Boscaro M, Fallo F. Pharmacologic management of Cushing syndrome: new targets for therapy. Treat Endocrinol. 2005;4(2):87–94.CrossRefPubMedGoogle Scholar
  15. 15.
    Sonino N, Zielezny M, Fava GA, Fallo F, Boscaro M. Risk factors and long-term outcome in pituitary-dependent Cushing’s disease. J Clin Endocrinol Metab. 1996;81(7):2647–2652.CrossRefPubMedGoogle Scholar
  16. 16.
    Conn JW, Louis LH. Primary aldosteronism: a new clinical entity. Trans Assoc Am Physicians. 1955;68:215–231.PubMedGoogle Scholar
  17. 17.
    Lim PO, Dow E, Brennan G, Jung RT, Macdonald TM. High prevalence of primary aldosteronism in the Tayside hypertension clinic population. J Hum Hypertens. 2000;14(5):311–315.CrossRefPubMedGoogle Scholar
  18. 18.
    Rossi GP, Bernini G, Caliumi C, et al. A prospective study of the prevalence of primary aldosteronism in 1, 125 hypertensive patients. J Am Coll Cardiol. 2006;48(11):2293–2300.CrossRefPubMedGoogle Scholar
  19. 19.
    Kaplan NM. Hypokalemia in the hypertensive patient, with observations on the incidence of primary aldosteronism. Ann Intern Med. 1967;66(6):1079–1090.PubMedGoogle Scholar
  20. 20.
    Sinclair AM, Isles CG, Brown I, Cameron H, Murray GD, Robertson JW. Secondary hypertension in a blood pressure clinic. Arch Intern Med. 1987;147(7):1289–1293.CrossRefPubMedGoogle Scholar
  21. 21.
    Young WF Jr. Minireview: primary aldosteronism - changing concepts in diagnosis and treatment. Endocrinology. 2003;144(6):2208–2213.CrossRefPubMedGoogle Scholar
  22. 22.
    Gordon RD, Stowasser M. Primary aldosteronism: the case for screening. Nat Clin Pract Nephrol. 2007;3(11):582–583.CrossRefPubMedGoogle Scholar
  23. 23.
    Mulatero P, Milan A, Fallo F, et al. Comparison of confirmatory tests for the diagnosis of primary aldosteronism. J Clin Endocrinol Metab. 2006;91(7):2618–2623.CrossRefPubMedGoogle Scholar
  24. 24.
    Lingam RK, Sohaib SA, Rockall AG, et al. Diagnostic performance of CT versus MR in detecting aldosterone-producing adenoma in primary hyperaldosteronism (Conn’s syndrome). Eur Radiol. 2004;14(10):1787–1792.CrossRefPubMedGoogle Scholar
  25. 25.
    Young WF, Stanson AW, Thompson GB, Grant CS, Farley DR, van Heerden JA. Role for adrenal venous sampling in primary aldosteronism. Surgery. 2004;136(6):1227–1235.CrossRefPubMedGoogle Scholar
  26. 26.
    Harvey A, Kline G, Pasieka JL. Adrenal venous sampling in primary hyperaldosteronism: comparison of radiographic with biochemical success and the clinical decision-making with “less than ideal” testing. Surgery. 2006;140(6):847–853.CrossRefPubMedGoogle Scholar
  27. 27.
    Rossi GP, Sacchetto A, Chiesura-Corona M, et al. Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases. J Clin Endocrinol Metab. 2001;86(3):1083–1090.CrossRefPubMedGoogle Scholar
  28. 28.
    Sawka AM, Young WF, Thompson GB, et al. Primary aldosteronism: factors associated with normalization of blood pressure after surgery. Ann Intern Med. 2001;135(4):258–261.PubMedGoogle Scholar
  29. 29.
    Sywak M, Pasieka JL. Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism. Br J Surg. 2002;89(12):1587–1593.CrossRefPubMedGoogle Scholar
  30. 30.
    Sheps SG, Jiang NS, Klee GG. Diagnostic evaluation of pheochromocytoma. Endocrinol Metab Clin North Am. 1988;17(2):397–414.PubMedGoogle Scholar
  31. 31.
    Yeo H, Roman S. Pheochromocytoma and functional paraganglioma. Curr Opin Oncol. 2005;17(1):13–18.CrossRefPubMedGoogle Scholar
  32. 32.
    Kudva YC, Sawka AM, Young WF Jr. Clinical review 164: the laboratory diagnosis of adrenal pheochromocytoma: the Mayo Clinic experience. J Clin Endocrinol Metab. 2003;88(10):4533–4539.CrossRefPubMedGoogle Scholar
  33. 33.
    Elder EE, Elder G, Larsson C. Pheochromocytoma and functional paraganglioma syndrome: no longer the 10% tumor. J Surg Oncol. 2005;89(3):193–201.CrossRefPubMedGoogle Scholar
  34. 34.
    Madani R, Al Hashmi M, Bliss R, Lennard TW. Ectopic pheochromocytoma: does the rule of tens apply? World J Surg. 2007;31(4):849–854.CrossRefPubMedGoogle Scholar
  35. 35.
    Neumann HP, Bausch B, McWhinney SR, et al. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med. 2002;346(19):1459–1466.CrossRefPubMedGoogle Scholar
  36. 36.
    Young WF, Jr. Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota. Endocrinol Metab Clin North Am. 2000;29(1):159-185, x.CrossRefPubMedGoogle Scholar
  37. 37.
    Sawka AM, Jaeschke R, Singh RJ, Young WF Jr. A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab. 2003;88(2):553–558.CrossRefPubMedGoogle Scholar
  38. 38.
    Pacak K, Eisenhofer G, Ahlman H, et al. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nat Clin Pract Endocrinol Metab. 2007;3(2):92–102.CrossRefPubMedGoogle Scholar
  39. 39.
    Boyle JG, Davidson DF, Perry CG, Connell JM. Comparison of diagnostic accuracy of urinary free metanephrines, vanillyl mandelic Acid, and catecholamines and plasma catecholamines for diagnosis of pheochromocytoma. J Clin Endocrinol Metab. 2007;92(12):4602–4608.CrossRefPubMedGoogle Scholar
  40. 40.
    Lenders JW, Pacak K, Walther MM, et al. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA. 2002;287(11):1427–1434.CrossRefPubMedGoogle Scholar
  41. 41.
    Grossman A, Pacak K, Sawka A, et al. Biochemical diagnosis and localization of pheochromocytoma: can we reach a consensus? Ann N Y Acad Sci. 2006;1073:332–347.CrossRefPubMedGoogle Scholar
  42. 42.
    Miskulin J, Shulkin BL, Doherty GM, Sisson JC, Burney RE, Gauger PG. Is preoperative iodine 123 meta-iodobenzylguanidine scintigraphy routinely necessary before initial adrenalectomy for pheochromocytoma? Surgery. 2003;134(6):918–922.CrossRefPubMedGoogle Scholar
  43. 43.
    Lebuffe G, Dosseh ED, Tek G, et al. The effect of calcium channel blockers on outcome following the surgical treatment of phaeochromocytomas and paragangliomas. Anaesthesia. 2005;60(5):439–444.CrossRefPubMedGoogle Scholar
  44. 44.
    Modlin IM, Farndon JR, Shepherd A, et al. Phaeochromocytomas in 72 patients: clinical and diagnostic features, treatment and long term results. Br J Surg. 1979;66(7):456–465.CrossRefPubMedGoogle Scholar
  45. 45.
    Poulose BK, Holzman MD, Lao OB, Grogan EL, Goldstein RE. Laparoscopic adrenalectomy: 100 resections with clinical long-term follow-up. Surg Endosc. 2005;19(3):379–385.CrossRefPubMedGoogle Scholar
  46. 46.
    Wilhelm SM, Prinz RA, Barbu AM, Onders RP, Solorzano CC. Analysis of large versus small pheochromocytomas: operative approaches and patient outcomes. Surgery. 2006;140(4):553–559.CrossRefPubMedGoogle Scholar
  47. 47.
    Dimas S, Roukounakis N, Kafetzis I, et al. Feasibility of laparoscopic adrenalectomy for large pheochromocytomas. JSLS. 2007;11(1):30–33.PubMedGoogle Scholar
  48. 48.
    Costello GT, Moorthy SS, Vane DW, Dierdorf SF. Hypoglycemia following bilateral adrenalectomy for pheochromocytoma. Crit Care Med. 1988;16(5):562–563.CrossRefPubMedGoogle Scholar
  49. 49.
    Mannelli M. Management and treatment of pheochromocytomas and paragangliomas. Ann N Y Acad Sci. 2006;1073:405–416.CrossRefPubMedGoogle Scholar
  50. 50.
    Nap RR, Meinardi JR, van den Berg G, Dullaart RP, de Vries J, Wolffenbuttel BH. [Long-term follow-up is indicated after surgery for a phaeochromocytoma]. Ned Tijdschr Geneeskd. 2006;150(19):1045–1049.PubMedGoogle Scholar
  51. 51.
    Vaughan ED Jr. Diseases of the adrenal gland. Med Clin North Am. 2004;88(2):443–466.CrossRefPubMedGoogle Scholar
  52. 52.
    Icard P, Goudet P, Charpenay C, et al. Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group. World J Surg. 2001;25(7):891–897.CrossRefPubMedGoogle Scholar
  53. 53.
    Tauchmanova L, Colao A, Marzano LA, et al. Andrenocortical carcinomas: twelve-year prospective experience. World J Surg. 2004;28(9):896–903.CrossRefPubMedGoogle Scholar
  54. 54.
    Sturgeon C, Shen WT, Clark OH, Duh QY, Kebebew E. Risk assessment in 457 adrenal cortical carcinomas: how much does tumor size predict the likelihood of malignancy? J Am Coll Surg. 2006;202(3):423–430.CrossRefPubMedGoogle Scholar
  55. 55.
    Terzolo M, Ali A, Osella G, Mazza E. Prevalence of adrenal carcinoma among incidentally discovered adrenal masses. A retrospective study from 1989 to 1994. Gruppo Piemontese Incidentalomi Surrenalici. Arch Surg. 1997;132(8):914–919.PubMedGoogle Scholar
  56. 56.
    Fajardo R, Montalvo J, Velazquez D, et al. Correlation between radiologic and pathologic dimensions of adrenal masses. World J Surg. 2004;28(5):494–497.CrossRefPubMedGoogle Scholar
  57. 57.
    Meyer A, Niemann U, Behrend M. Experience with the surgical treatment of adrenal cortical carcinoma. Eur J Surg Oncol. 2004;30(4):444–449.CrossRefPubMedGoogle Scholar
  58. 58.
    Duh QY. Laparoscopic adrenalectomy for isolated adrenal metastasis: the right thing to do and the right way to do it. Ann Surg Oncol. 2007;14(12):3288–3289.CrossRefPubMedGoogle Scholar
  59. 59.
    Porpiglia F, Fiori C, Tarabuzzi R, et al. Is laparoscopic adrenalectomy feasible for adrenocortical carcinoma or metastasis? BJU Int. 2004;94(7):1026–1029.CrossRefPubMedGoogle Scholar
  60. 60.
    Weitz J, Blumgart LH, Fong Y, et al. Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma. Ann Surg. 2005;241(2):269–276.CrossRefPubMedGoogle Scholar
  61. 61.
    Decker RA, Elson P, Hogan TF, et al. Eastern Cooperative Oncology Group study 1879: mitotane and adriamycin in patients with advanced adrenocortical carcinoma. Surgery. 1991;110(6):1006–1013.PubMedGoogle Scholar
  62. 62.
    Fassnacht M, Hahner S, Polat B, et al. Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma. J Clin Endocrinol Metab. 2006;91(11):4501–4504.CrossRefPubMedGoogle Scholar
  63. 63.
    Abrams HL, Spiro R, Goldstein N. Metastases in carcinoma; analysis of 1000 autopsied cases. Cancer. 1950;3(1):74–85.CrossRefPubMedGoogle Scholar
  64. 64.
    Sarela AI, Murphy I, Coit DG, Conlon KC. Metastasis to the adrenal gland: the emerging role of laparoscopic surgery. Ann Surg Oncol. 2003;10(10):1191–1196.CrossRefPubMedGoogle Scholar
  65. 65.
    Kim SH, Brennan MF, Russo P, Burt ME, Coit DG. The role of surgery in the treatment of clinically isolated adrenal metastasis. Cancer. 1998;82(2):389–394.CrossRefPubMedGoogle Scholar
  66. 66.
    Bovio S, Cataldi A, Reimondo G, et al. Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Invest. 2006;29(4):298–302.PubMedGoogle Scholar
  67. 67.
    Angeli A, Osella G, Ali A, Terzolo M. Adrenal incidentaloma: an overview of clinical and epidemiological data from the National Italian Study Group. Horm Res. 1997;47(4-6):279–283.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Adrian M. Harvey
    • 1
  • Allan A. Siperstein
    • 2
  • Eren Berber
    • 3
  1. 1.Department of SurgeryFoothills Medical CenterCalgaryCanada
  2. 2.Department of Endocrine SurgeryCleveland Clinic, Surgery InstituteClevelandUSA
  3. 3.Division of Endocrine SurgeryEndocrine and Metabolism Institute, Cleveland ClinicClevelandUSA

Personalised recommendations